Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.

Nicolaos Christodoulides, Floriano N. Pierre, Ximena Sanchez, Luanyi Li, Kyle Hocquard, Aaron Patton, Rachna Muldoon, Craig S. Miller, Jeffrey L. Ebersole, Spencer Redding, Chih Ko Yeh, Wieslaw B. Furmaga, David A. Wampler, Biykem Bozkurt, Christie M. Ballantyne, John McDevitt

Research output: Contribution to journalArticle

Abstract

Cardiovascular disease remains the leading cause of death in the world and continues to serve as the major contributor to healthcare costs. Likewise, there is an ever-increasing need and demand for novel and more efficient diagnostic tools for the early detection of cardiovascular disease, especially at the point-of-care (POC). This article reviews the programmable bio-nanochip (P-BNC) system, a new medical microdevice approach with the capacity to deliver both high performance and reduced cost. This fully integrated, total analysis system leverages microelectronic components, microfabrication techniques, and nanotechnology to noninvasively measure multiple cardiac biomarkers in complex fluids, such as saliva, while offering diagnostic accuracy equal to laboratory-confined reference methods. This article profiles the P-BNC approach, describes its performance in real-world testing of clinical samples, and summarizes new opportunities for medical microdevices in the field of cardiac diagnostics.

Original languageEnglish (US)
Pages (from-to)6-12
Number of pages7
JournalMethodist DeBakey cardiovascular journal
Volume8
Issue number1
StatePublished - Jan 2012

Fingerprint

Point-of-Care Systems
Cardiovascular Diseases
Microtechnology
Technology
Nanotechnology
Saliva
Health Care Costs
Early Diagnosis
Cause of Death
Biomarkers
Costs and Cost Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care. / Christodoulides, Nicolaos; Pierre, Floriano N.; Sanchez, Ximena; Li, Luanyi; Hocquard, Kyle; Patton, Aaron; Muldoon, Rachna; Miller, Craig S.; Ebersole, Jeffrey L.; Redding, Spencer; Yeh, Chih Ko; Furmaga, Wieslaw B.; Wampler, David A.; Bozkurt, Biykem; Ballantyne, Christie M.; McDevitt, John.

In: Methodist DeBakey cardiovascular journal, Vol. 8, No. 1, 01.2012, p. 6-12.

Research output: Contribution to journalArticle

Christodoulides, N, Pierre, FN, Sanchez, X, Li, L, Hocquard, K, Patton, A, Muldoon, R, Miller, CS, Ebersole, JL, Redding, S, Yeh, CK, Furmaga, WB, Wampler, DA, Bozkurt, B, Ballantyne, CM & McDevitt, J 2012, 'Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.', Methodist DeBakey cardiovascular journal, vol. 8, no. 1, pp. 6-12.
Christodoulides N, Pierre FN, Sanchez X, Li L, Hocquard K, Patton A et al. Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care. Methodist DeBakey cardiovascular journal. 2012 Jan;8(1):6-12.
Christodoulides, Nicolaos ; Pierre, Floriano N. ; Sanchez, Ximena ; Li, Luanyi ; Hocquard, Kyle ; Patton, Aaron ; Muldoon, Rachna ; Miller, Craig S. ; Ebersole, Jeffrey L. ; Redding, Spencer ; Yeh, Chih Ko ; Furmaga, Wieslaw B. ; Wampler, David A. ; Bozkurt, Biykem ; Ballantyne, Christie M. ; McDevitt, John. / Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care. In: Methodist DeBakey cardiovascular journal. 2012 ; Vol. 8, No. 1. pp. 6-12.
@article{e86315dc93eb48c5bda3ec50ad312bd9,
title = "Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.",
abstract = "Cardiovascular disease remains the leading cause of death in the world and continues to serve as the major contributor to healthcare costs. Likewise, there is an ever-increasing need and demand for novel and more efficient diagnostic tools for the early detection of cardiovascular disease, especially at the point-of-care (POC). This article reviews the programmable bio-nanochip (P-BNC) system, a new medical microdevice approach with the capacity to deliver both high performance and reduced cost. This fully integrated, total analysis system leverages microelectronic components, microfabrication techniques, and nanotechnology to noninvasively measure multiple cardiac biomarkers in complex fluids, such as saliva, while offering diagnostic accuracy equal to laboratory-confined reference methods. This article profiles the P-BNC approach, describes its performance in real-world testing of clinical samples, and summarizes new opportunities for medical microdevices in the field of cardiac diagnostics.",
author = "Nicolaos Christodoulides and Pierre, {Floriano N.} and Ximena Sanchez and Luanyi Li and Kyle Hocquard and Aaron Patton and Rachna Muldoon and Miller, {Craig S.} and Ebersole, {Jeffrey L.} and Spencer Redding and Yeh, {Chih Ko} and Furmaga, {Wieslaw B.} and Wampler, {David A.} and Biykem Bozkurt and Ballantyne, {Christie M.} and John McDevitt",
year = "2012",
month = "1",
language = "English (US)",
volume = "8",
pages = "6--12",
journal = "Methodist DeBakey cardiovascular journal",
issn = "1947-6094",
publisher = "Methodist DeBakey Heart & Vascular Center",
number = "1",

}

TY - JOUR

T1 - Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.

AU - Christodoulides, Nicolaos

AU - Pierre, Floriano N.

AU - Sanchez, Ximena

AU - Li, Luanyi

AU - Hocquard, Kyle

AU - Patton, Aaron

AU - Muldoon, Rachna

AU - Miller, Craig S.

AU - Ebersole, Jeffrey L.

AU - Redding, Spencer

AU - Yeh, Chih Ko

AU - Furmaga, Wieslaw B.

AU - Wampler, David A.

AU - Bozkurt, Biykem

AU - Ballantyne, Christie M.

AU - McDevitt, John

PY - 2012/1

Y1 - 2012/1

N2 - Cardiovascular disease remains the leading cause of death in the world and continues to serve as the major contributor to healthcare costs. Likewise, there is an ever-increasing need and demand for novel and more efficient diagnostic tools for the early detection of cardiovascular disease, especially at the point-of-care (POC). This article reviews the programmable bio-nanochip (P-BNC) system, a new medical microdevice approach with the capacity to deliver both high performance and reduced cost. This fully integrated, total analysis system leverages microelectronic components, microfabrication techniques, and nanotechnology to noninvasively measure multiple cardiac biomarkers in complex fluids, such as saliva, while offering diagnostic accuracy equal to laboratory-confined reference methods. This article profiles the P-BNC approach, describes its performance in real-world testing of clinical samples, and summarizes new opportunities for medical microdevices in the field of cardiac diagnostics.

AB - Cardiovascular disease remains the leading cause of death in the world and continues to serve as the major contributor to healthcare costs. Likewise, there is an ever-increasing need and demand for novel and more efficient diagnostic tools for the early detection of cardiovascular disease, especially at the point-of-care (POC). This article reviews the programmable bio-nanochip (P-BNC) system, a new medical microdevice approach with the capacity to deliver both high performance and reduced cost. This fully integrated, total analysis system leverages microelectronic components, microfabrication techniques, and nanotechnology to noninvasively measure multiple cardiac biomarkers in complex fluids, such as saliva, while offering diagnostic accuracy equal to laboratory-confined reference methods. This article profiles the P-BNC approach, describes its performance in real-world testing of clinical samples, and summarizes new opportunities for medical microdevices in the field of cardiac diagnostics.

UR - http://www.scopus.com/inward/record.url?scp=84870516252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870516252&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 6

EP - 12

JO - Methodist DeBakey cardiovascular journal

JF - Methodist DeBakey cardiovascular journal

SN - 1947-6094

IS - 1

ER -